Found: 15
Select item for more details and to access through your institution.
Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC).
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 6, p. 954, doi. 10.1002/psp4.13130
- By:
- Publication type:
- Article
Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 4, p. 498, doi. 10.1002/jcph.2192
- By:
- Publication type:
- Article
Model‐Based Analysis of the Influence of Alcohol Use and Age on Pharmacokinetics‐Pharmacodynamics of Oral Oxycodone in Middle‐Age and Older Community‐Dwelling Adults.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 9, p. 1177, doi. 10.1002/jcph.2058
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure‐Response Analyses for the Most Frequent Adverse Events Following Treatment With Lemborexant, an Orexin Receptor Antagonist, in Subjects With Insomnia Disorder.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 12, p. 1642, doi. 10.1002/jcph.1683
- By:
- Publication type:
- Article
Modeling Dropout From Adverse Event Data: Impact of Dosing Regimens Across Pregabalin Trials in the Treatment of Generalized Anxiety Disorder.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 5, p. 706, doi. 10.1177/0091270010370973
- By:
- Publication type:
- Article
Models for Event-Driven Data: Longitudinal Daily Adverse Event and Dropout.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 9, p. 58S, doi. 10.1177/0091270010376975
- By:
- Publication type:
- Article
E2814: an anti‐tau therapy engages its CNS target and affects the downstream tangle‐specific biomarker MTBR‐tau243 in Dominantly Inherited Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082771
- By:
- Publication type:
- Article
Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 5, p. 455, doi. 10.1002/psp4.12606
- By:
- Publication type:
- Article
Opportunities and Challenges of Disease Progression Modeling in Drug Development – An IQ Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 266, doi. 10.1002/cpt.2873
- By:
- Publication type:
- Article
Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 754, doi. 10.1002/cpt.2448
- By:
- Publication type:
- Article
Dexmedetomidine Pharmacokinetics in Neonates with Hypoxic-Ischemic Encephalopathy Receiving Hypothermia.
- Published in:
- Anesthesiology Research & Practice, 2020, p. 1, doi. 10.1155/2020/2582965
- By:
- Publication type:
- Article
Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 681, doi. 10.1002/cpdd.915
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 153, doi. 10.1002/cpdd.817
- By:
- Publication type:
- Article
Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 5, p. 461, doi. 10.1016/j.clpt.2006.01.009
- By:
- Publication type:
- Article